Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Phase I Open-Label Study Evaluating the Safety and Feasibility of Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

Disease Sites:

Head/Neck

Staging:

Phase I

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Rosenthal, Eben

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

10-14-2026

Trial Type:

Diagnostic

Protocol ID:

VICCHNP26039

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available